CHU de Nice
Nice, France
Location status: Recruiting
Location contact
Guillaume SACCO
PRINCIPAL_INVESTIGATOR
Justine Lemaire
CONTACT
NCT Number: NCT06192953
The main objective of our study is to evaluate the impact of the use of Functional Proprioceptive Stimulation (FPS) on the recovery of the postural and motor functional capacities of the patient in the subacute phase of a stroke.
The hypothesis is that the use of FPS has a positive impact on the recovery of the patient's functional abilities, as well as on the duration of treatment until the sit/stand transfers are completed.
To evaluate this potential effect,there will be a randomization with two groups : one will have 5 sessions a week for 6 weeks maximum of SPF and the other groupe will have the same sessions but with the device stettled but not activated.
Interested in participating?
Request Info18 year–100 year
All sexes
Interventional
Not applicable
Nice, France
Location status: Recruiting
Guillaume SACCO
PRINCIPAL_INVESTIGATOR
Justine Lemaire
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Orthoses with a system of 12 stimulators producing mechanical oscillations are attached to the joints of the upper limbs (wrist, elbow and shoulder) or lower limb joints (ankle, knee, hip). These stimulators, which are all synchronized, deliver mechanical oscillations (FPS) that give the illusion of complex movements, while the patient is bedridden, neither moving nor producing effort.
Time frame: Inclusion
The SFPASS is a short instrument used to assess balance in lying, sitting and standing positions. It was designed specifically for stroke patients and is appropriate for all individuals, regardless of their postural performance. SFPASS focuses on mobility in bed and sitting to standing transfer. It is composed of 5 items rated on a 3-point scale with total scores ranging from 0 to 15 and is evaluated by a health professional.
Time frame: Every week during 5 weeks maximum
The SFPASS is a short instrument used to assess balance in lying, sitting and standing positions. It was designed specifically for stroke patients and is appropriate for all individuals, regardless of their postural performance. SFPASS focuses on mobility in bed and sitting to standing transfer. It is composed of 5 items rated on a 3-point scale with total scores ranging from 0 to 15 and is evaluated by a health professional.
Time frame: 6 weeks
The SFPASS is a short instrument used to assess balance in lying, sitting and standing positions. It was designed specifically for stroke patients and is appropriate for all individuals, regardless of their postural performance. SFPASS focuses on mobility in bed and sitting to standing transfer. It is composed of 5 items rated on a 3-point scale with total scores ranging from 0 to 15 and is evaluated by a health professional.
Time frame: 10 weeks
The SFPASS is a short instrument used to assess balance in lying, sitting and standing positions. It was designed specifically for stroke patients and is appropriate for all individuals, regardless of their postural performance. SFPASS focuses on mobility in bed and sitting to standing transfer. It is composed of 5 items rated on a 3-point scale with total scores ranging from 0 to 15 and is evaluated by a health professional.
Contact information is provided by the study sponsor or research team.
Guillaume SACCO, MD
CONTACT
Justine LEMAIRE
CONTACT
Centre Hospitalier Universitaire de Nice
Other
Acronym: StimProF
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07723300
Brain Diseases, Cardiovascular Diseases
Columbus, Ohio, United States
View Trial DetailsNCT07419087
Brain Diseases, Brain Ischemia
Ploemeur, Please Choose..., France
View Trial DetailsNCT07562178
Brain Diseases, Cardiovascular Diseases
Hizume, Iwate, Japan
View Trial DetailsNCT07556887
Arterial Occlusive Diseases, Arteriosclerosis
Arnhem, Gelderland, Netherlands
View Trial Details